pk 11195 has been researched along with Lung Diseases, Interstitial in 1 studies
PK-11195 : A monocarboxylic acid amide obtained by formal condensation of the carboxy group of 1-(2-chlorophenyl)isoquinoline-3-carboxylic acid with the amino group of sec-butylmethylamine
Lung Diseases, Interstitial: A diverse group of lung diseases that affect the lung parenchyma. They are characterized by an initial inflammation of PULMONARY ALVEOLI that extends to the interstitium and beyond leading to diffuse PULMONARY FIBROSIS. Interstitial lung diseases are classified by their etiology (known or unknown causes), and radiological-pathological features.
| Timeframe | Studies, this research(%) | All Research% |
|---|---|---|
| pre-1990 | 0 (0.00) | 18.7374 |
| 1990's | 0 (0.00) | 18.2507 |
| 2000's | 1 (100.00) | 29.6817 |
| 2010's | 0 (0.00) | 24.3611 |
| 2020's | 0 (0.00) | 2.80 |
| Authors | Studies |
|---|---|
| Branley, HM | 1 |
| du Bois, RM | 1 |
| Wells, AU | 1 |
| Jones, HA | 1 |
1 other study available for pk 11195 and Lung Diseases, Interstitial
| Article | Year |
|---|---|
Peripheral-type benzodiazepine receptors in bronchoalveolar lavage cells of patients with interstitial lung disease.
Topics: Bronchoalveolar Lavage Fluid; Cells, Cultured; Deuterium; Extracellular Fluid; Humans; Isoquinolines | 2007 |